Table II.
Rest | αCD3 | αCD3 + P3C (10 μg/ml) | αCD3 + αCD28 | αCD3+ αCD28 + P3C (10 μg/ml) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||
Neonate | Adult | Neonate | Adult | Neonate | Adult | Neonate | Adult | Neonate | Adult | |
CD25 | 2.6 ± 1 | 2.4 ± 1 | 29 ± 7 | 23 ± 8 | 53 ± 8* | 39* ± 9 | 31* ± 7 | 28 ± 9 | 55 ± 7* | 40 ± 10* |
CD69 | 0.2 ± 0.1 | 0.3 ± 0.1 | 40 ± 8* | 59 ± 5* | 57 ± 8* | 62 ± 5* | 40 ± 9* | 61 ± 6* | 56 ± 9* | 64 ± 4* |
CD154 | 1.1 ± 1 | 0.2 ± 0.1 | 24 ± 8 | 29 ± 4 | 49 ± 14* | 48 ± 9* | 24 ± 8 | 28 ± 5 | 50 ± 14* | 47 ± 10* |
Expression of individual activation markers (CD25, CD69, and CD541) on highly purified naïve CD4+ T cells from neonatal and adult donors stimulated for 18 h under the indicated conditions (shown are mean percentage ± SEM from 8 experiments using 8 adult and 8 cord donors). There were no significant differences in expression of any activation markers under the tested conditions between neonatal and adult donors.
Indicates p-value < 0.01 for within age-group comparison of stimulated to resting condition using two-way ANOVA followed by Tukey-Kramer adjustment for multiple comparisons.